Kamil D. Kaplanov
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The role of the PPM1D gene in tumor pathogenesis.
Journal: Biomeditsinskaia khimiia
Published: March 06, 2025
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 06, 2023
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
Journal: Leukemia
Published: November 24, 2022
Five year experience in ibrutinib therapy for relapsed and refractory mantle cell lymphoma in real world Russian clinical practice
Journal: Terapevticheskii arkhiv
Published: July 20, 2021
Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma
Journal: Terapevticheskii arkhiv
Published: April 16, 2020
Can Less Intensive Chemotherapy and an Autotransplant Cure Adult T-Cell Acute Lymphoblastic Leukemia?
Journal: Acta haematologica
Published: July 24, 2019
Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial.
Journal: Hematological oncology
Published: July 09, 2019
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial.
Journal: British journal of haematology
Published: September 25, 2018
Adult B-cell acute lymphoblastic leukemias: Conclusions of the Russian prospective multicenter study ALL-2009
Journal: Terapevticheskii arkhiv
Published: August 03, 2017
Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 03, 2016
Acute Ph-negative lymphoblastic leukemias in adults: Risk factors in the use of the ALL-2009 protocol
Journal: Terapevticheskii arkhiv
Published: July 27, 2016
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.
Journal: The Lancet. Oncology
Published: October 01, 2015
Last Updated: 09/26/2026